Follow
Andrzej Stepulak
Andrzej Stepulak
Head of the Dept. of Biochemistry and Molecular Biology, Medical University in Lublin, Poland
Verified email at umlub.pl
Title
Cited by
Cited by
Year
Comprehensive review on betulin as a potent anticancer agent
SK Król, M Kiełbus, A Rivero-Müller, A Stepulak
BioMed research international 2015, 2015
2382015
Expression of glutamate receptor subunits in human cancers
A Stepulak, H Luksch, C Gebhardt, O Uckermann, J Marzahn, M Sifringer, ...
Histochemistry and cell biology 132, 435-445, 2009
2232009
Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain
HH Hansen, T Briem, M Dzietko, M Sifringer, A Voss, W Rzeski, ...
Neurobiology of disease 16 (2), 440-453, 2004
2072004
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth
A Stepulak, M Sifringer, W Rzeski, S Endesfelder, A Gratopp, EE Pohl, ...
Proceedings of the National Academy of Sciences 102 (43), 15605-15610, 2005
1722005
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells
W Rzeski, A Stepulak, M Szymański, M Sifringer, J Kaczor, K Wejksza, ...
Naunyn-Schmiedeberg's archives of pharmacology 374, 11-20, 2006
1702006
Glutamate and its receptors in cancer
A Stepulak, R Rola, K Polberg, C Ikonomidou
Journal of neural transmission 121, 933-944, 2014
1642014
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
N Tanaka, S Kanatani, R Tomer, C Sahlgren, P Kronqvist, D Kaczynska, ...
Nature Biomedical Engineering 1 (10), 796-806, 2017
1632017
The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase
T He, A Stepulak, TH Holmström, MB Omary, JE Eriksson
Journal of Biological Chemistry 277 (13), 10767-10774, 2002
1522002
Glutamate receptors in pediatric tumors of the central nervous system
KS Brocke, C Staufner, H Luksch, KD Geiger, A Stepulak, J Marzahn, ...
Cancer biology & therapy 9 (6), 455-468, 2010
1312010
Silencing of selected glutamate receptor subunits modulates cancer growth
H Luksch, O Uckermann, A Stepulak, S Hendruschk, J Marzahn, ...
Anticancer research 31 (10), 3181-3192, 2011
1082011
Betulin Elicits Anti‐Cancer Effects in Tumour Primary Cultures and Cell Lines In Vitro
W Rzeski, A Stepulak, M Szymański, M Juszczak, A Grabarska, ...
Basic & clinical pharmacology & toxicology 105 (6), 425-432, 2009
932009
MicroRNAs-role in lung cancer
M Guz, A Rivero-Müller, E Okoń, A Stenzel-Bembenek, K Polberg, ...
Disease markers 2014, 2014
922014
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells
A Stepulak, W Rzeski, M Sifringer, K Brocke, A Gratopp, K Kupisz, L Turski, ...
Cancer biology & therapy 7 (10), 1685-1693, 2008
922008
Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood
A Szuster-Ciesielska, E Hryciuk-Umer, A Stepulak, K Kupisz, ...
Acta oncologica 43 (3), 252-258, 2004
912004
Histone deacetylase inhibitors and phenotypical transformation of cancer cells
A Wawruszak, J Kalafut, E Okon, J Czapinski, M Halasa, ...
Cancers 11 (2), 148, 2019
842019
The role of matrix metalloproteinases in infant traumatic brain injury
M Sifringer, V Stefovska, I Zentner, B Hansen, A Stepulak, C Knaute, ...
Neurobiology of disease 25 (3), 526-535, 2007
732007
Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines–An isobolographic analysis
A Wawruszak, JJ Luszczki, A Grabarska, E Gumbarewicz, ...
PLoS One 10 (11), e0143013, 2015
682015
H3K18Ac as a marker of cancer progression and potential target of anti-cancer therapy
M Hałasa, A Wawruszak, A Przybyszewska, A Jaruga, M Guz, J Kałafut, ...
Cells 8 (5), 485, 2019
572019
7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro
M KIEŁBUS, K SKALICKA-WOŹNIAK, A Grabarska, W Jeleniewicz, ...
Anticancer research 33 (10), 4347-4356, 2013
542013
Histone deacetylase inhibitor SAHA as potential targeted therapy agent for larynx cancer cells
A Grabarska, JJ Łuszczki, E Nowosadzka, E Gumbarewicz, W Jeleniewicz, ...
Journal of Cancer 8 (1), 19, 2017
512017
The system can't perform the operation now. Try again later.
Articles 1–20